Location History:
- St. Louis, MO (US) (2013)
- Saint Louis, MO (US) (2015 - 2021)
Company Filing History:
4 out of 1,299 
1 out of 818 
1 out of 3,540 
Years Active: 2013-2021
Title: Daniel S Ory: Pioneering Innovations in Cardiovascular Disease Risk Assessment and Niemann-Pick Disease Detection
Introduction:
In the dynamic world of health sciences, visionary inventors make groundbreaking contributions that enhance our understanding of diseases and revolutionize diagnostic methods. Among these influential figures is Daniel S Ory, an enthusiast in the field of cardiovascular disease risk assessment and the detection of Niemann-Pick diseases. With an impressive collection of patents and a rich career history, Ory has left an indelible mark on the scientific community. This article shines a light on his remarkable achievements and influential collaborations.
Latest Patents:
Daniel S Ory's latest patents have significantly impacted the fields of cardiovascular disease evaluation and the detection of Niemann-Pick diseases. In one recent invention, "Ceramides for Evaluating Risk of Cardiovascular Disease," Ory introduces the use of two very long chain ceramides for determining an individual's susceptibility to cardiovascular disease. This innovation holds the potential to enhance early detection and aid in the prevention of this prevalent condition.
Additionally, Ory's patent titled "Bile Acid Biomarkers for Niemann-Pick Diseases, Methods and Uses Therefore" presents methods for the identification and quantification of bile acids to identify individuals with Niemann-Pick diseases. This invention uses bile acid measurements in plasma, serum, or dried blood spots to identify subjects with Niemann-Pick A/B and differentiate them from those with Niemann-Pick C (NPC) disease. These groundbreaking detection methods employ mass spectroscopy and liquid chromatography, facilitating accurate diagnoses and advancing treatment strategies.
Career Highlights:
Throughout his career, Ory has made significant contributions in prominent institutions. His expertise has been valued at Washington University, where he brought his visionary ideas to fruition. Moreover, Ory's tenure at Boston University exemplified his commitment to advancing the understanding of various diseases, propelling the field forward with his innovative research.
Collaborations:
In the realm of scientific exploration, collaborations play a vital role in driving innovation. Daniel S Ory has had the privilege of working alongside esteemed colleagues, including Forbes D Porter III and Jean E Schaffer. These fruitful partnerships have fostered an environment of collaboration, leading to groundbreaking advancements in the field.
Conclusion:
Daniel S Ory's dedication to advancing cardiovascular disease risk assessment and the detection of Niemann-Pick diseases has significantly influenced the medical landscape. With his inventive mindset and tireless efforts, Ory has propelled the understanding and diagnosis of these diseases to new heights. As his patents and career trajectory exemplify, Ory's contributions will continue to inspire future generations of inventors and revolutionize the field of health sciences.